Title: Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: An extended phase I/II study of the German testicular cancer study group
Authors: Schmoll, HJ ×
Kollmannsberger, C
Metzner, B
Hartmann, JT
Schleucher, N
Schöffski, Patrick
Schleicher, J
Rick, O
Beyer, J
Hossfeld, D
Kanz, L
Berdel, WE
Andreesen, R
Bokemeyer, C #
Issue Date: Nov-2003
Publisher: Grune & Stratton
Series Title: Journal of Clinical Oncology vol:21 issue:22 pages:4083-4091
Abstract: Purpose : Patients with disseminated germ cell cancer and poor prognosis (international Germ Cell Cancer Collaborative Group [IGCCCG] classification) achieve only a 45% to 50% long-term survival by standard chemotherapy. First-line high-dose chemotherapy might be able to improve the result. This analysis reports toxicity and long-term results of a large phase I/II study of sequential high-dose etoposide, ifosfamide, and cisplatin (VIP) in patients with advanced germ cell tumors.
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Experimental Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science